Skip to main content
. 2018 Feb 1;7:e31895. doi: 10.7554/eLife.31895

Table 1. Clinical details.

Case Age/Gender Surgical center Disease duration (Years) Predominant symptoms UPDRS med ON/OFF Δ UPDRS [%] Stim ON/OFF* Medication decrease*
 1 59/M Berlin 10 Bradykinesia, Rigidity --/26 42% NA
 2 44/M Berlin 12 Bradykinesia, Rigidity,
Resting Tremor
31/41 25% NA
 3 42/M Berlin 4 Action Tremor, Resting Tremor, Gait Disturbance 16/42 60% 100%
 4 53/M Berlin 8 Bradykinesia, Rigidity,
Resting Tremor
3/20 53% 68%
 5 70/M Berlin 19 Bradykinesia, Rigidity,
Resting Tremor
38/48 NA NA
 6 55/M Berlin 15 Peak-Dose Dyskinesia, Wearing-Off 18/32 75% 50%
 7 71/F Berlin 18 Bradykinesia 17/34 39% 45.5%
 8 68/M Berlin 20 Speech Difficulties, Hypokinesia 16/20 40% 61.3%
 9 67/M Berlin 14 Bradykinesia 14/24 74% 50%
 10 49/M Hannover 7 Rigidity 19/40 50% 14.3%
 11 39/F Berlin 6 Resting Tremor,
Action Tremor
21/-- NA 68.4%
 12 71/M Berlin 4 Resting Tremor 20/23 NA 55.2%
 13 68/F Berlin 5 Resting Tremor 14/20 NA 74.3%
 14 58/M Berlin 12 Bradykinesia, Fluctuations, Freezing --/35 69% 36.3%
 15 75/M Berlin 15 Action Tremor,
Resting Tremor
20/38 69% 50%
 16 53/M Hannover 10 Bradykinesia, Rigidity 24/42 53% 33.3%%

*after 3 months post-operatively ** NA = not available archive data.